IQ-AI Limited

IQAI

JE00BD4H0R42

Healthcare Facilities & Services

Delayed London S.E. Other stock markets 09:52:38 2024-05-17 am EDT			5-day change	1st Jan Change
1.485 ^GBX	+10.00%		-10.00%	-68.40%

02:18pm	IQ-AI Unit Delivers Software to Insel Gruppe	MT
May. 10	IQ-AI subsidiary gets rare paediatric disease designation FDA	AN

Flying Brands Ltd. Announces Resignation of Christopher Knott as Group Finance Director and Company Secretary, effective 31 December 2013

November 15, 2013 at 02:00 am EST

Flying Brands Limited has accepted the resignation of Christopher Knott as Group Finance Director and Company Secretary. He will be leaving Flying Brands on 31 December 2013 to take up a new role.

Latest news about IQ-AI Limited

IQ-AI Unit Delivers Software to Insel Gruppe	08:18am	MT
IQ-AI subsidiary gets rare paediatric disease designation FDA	May. 10	AN
IQ-AI's Imaging Biometrics Obtains Rare Pediatric Disease Designation for Lead Drug Candidate	May. 10	MT
EARNINGS AND TRADING: Trident Royalties swings to profit	May. 02	AN
IQ-AI Limited Provides Revenue Guidance for the Financial Year 2024	Apr. 29	CI
IQ-AI Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 29	CI
IQ-AI's Broker Exercises Option to Buy Shares in Placing	Feb. 26	MT
IQ-AI Plans Share Placing to Advance Oral Anti-tumor Agent Development	Feb. 22	MT
IQ-AI shares sink on discounted placing fundraise	Feb. 22	AN
IQ-AI Unit to Revise, Resubmit Pediatric Rare Disease Designation Application After US FDA Feedback	Feb. 09	MT
IQ-AI subsidiary asked by FDA to resubmit and modify application	Feb. 09	AN
IQ-AI Unit Secures Grant for Brain Tumor Pill Access Program	Feb. 02	MT
IQ-AI celebrates USD100,000 grant for subsidiary	Feb. 02	AN
IQ-AI falls after subsidiary notes launch of treatment access scheme	Jan. 10	AN
IQ-AI's Imaging Biometrics Plans Expanded Access Program for Brain Tumor Treatment	Jan. 10	MT
IQ-AI Subsidiary’s Glioblastoma Therapy Obtains Fast-Track Designation From US FDA	Dec. 19	MT
IQ-AI firm gets US FDA fast-track status for oral gallium maltolate	Dec. 19	AN
IQ-AI's Imaging Biometrics Discloses Positive Results in Early-stage Study of Potential Brain Cancer Treatment	Dec. 05	MT
IQ-AI stock rises on positive interim results from glioblastoma trial	Dec. 05	AN
IQ-AI Unit Seeks Pediatric Rare Disease Designation for Brain Tumor Treatment	Nov. 08	MT
IQ-AI says Imaging Biometrics submits paediatric rare disease request	Nov. 08	AN
IQ-AI Applies for FDA Pediatric Rare Disease Designation	Nov. 08	CI
IQ-AI subsidiary "central" to "landmark" brain cancer study	23-10-18	AN
IQ-AI subsidiary wins orphan drug designation from US FDA	23-10-09	AN
IQ-AI's Atypical Teratoid Rhabdoid Tumor Treatment Gains US FDA Orphan Drug Designation	23-10-09	MT

IQ-AI Limited is a Jersey-based company, which is engaged in the provision of clinical treatments to patients in the field of medical imaging diagnostics, based on technology. The Company operates through two segments: holding company expenses and medical software. Its subsidiaries include Imaging Biometrics, LLC and Stone Checker Software Limited. Imaging Biometrics, LLC is a healthcare imaging software company. In addition to providing regulatory consulting services, Imaging Biometrics, LLC supplies medical technology solutions and has a neuroimaging product portfolio. Stone Checker Software Limited is a supplier of technology solutions in the field of kidney stone analysis and kidney stone prevention.

Sector

Healthcare Facilities & Services

Calendar

2024-05-29 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Medical & Diagnostic Laboratories

	1st Jan change	Capi.
IQ-AI LIMITED	-68.40%	3.79M
SONIC HEALTHCARE LIMITED	-16.99%	8.67B
RADNET, INC.	+67.54%	4.25B
DR. LAL PATHLABS LIMITED	-1.10%	2.51B
SYNLAB AG	-9.46%	2.47B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-44.11%	2.25B
NEOGENOMICS, INC.	-8.07%	1.91B
FLEURY S.A.	-19.46%	1.56B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-41.75%	1.19B
METROPOLIS HEALTHCARE LIMITED	+11.31%	1.15B

Medical & Diagnostic Laboratories

IQ-AI Limited

Equities

IQAI

JE00BD4H0R42

Healthcare Facilities & Services

Flying Brands Ltd. Announces Resignation of Christopher Knott as Group Finance Director and Company Secretary, effective 31 December 2013

Latest news about IQ-AI Limited

Chart IQ-AI Limited

Company Profile

Income Statement Evolution

Sector Medical & Diagnostic Laboratories